Sign in

CIK 0001133869

  • Non-accelerated filer
  • Smaller reporting company

CAPRICOR THERAPEUTICS, INC.

Sign in to watch
Ticker
CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 310-358-3200
Business address
10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
Former names
Nile Therapeutics, Inc., SMI PRODUCTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-13 Litvack Frank Director Option exercise +3,937 $1.39 $5K 133,776
2026-05-13 Litvack Frank Director Option exercise · Stock Option (Right to Buy) −3,937 0
2026-01-05 Litvack Frank Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2025-03-03 Litvack Frank Director Option exercise +25,000 $1.39 $35K 132,382
2025-03-03 Litvack Frank Director Shares withheld for taxes −2,543 $13.67 $35K 129,839
2025-03-03 Litvack Frank Director Option exercise · Stock Option (Right to Buy) −25,000 0
2025-01-02 Litvack Frank Director Grant or award · Stock Option (Right to Buy) +50,000 50,000
2024-12-03 Litvack Frank Director Option exercise +20,391 $1.10 $22K 46,278
2024-12-03 Litvack Frank Director Option exercise · Warrants (Right to Buy) −20,391 0
2024-12-02 Litvack Frank Director Gift · Warrants (Right to Buy) −20,391 0
2024-12-02 Litvack Frank Director Gift · Warrants (Right to Buy) +20,391 20,391
2024-01-02 Litvack Frank Director Grant or award · Stock Option (Right to Buy) +200,000 200,000
2023-08-14 Litvack Frank Director Option exercise +20,748 $1.39 $29K 137,633
2023-08-14 Litvack Frank Director Shares withheld for taxes −4,364 $6.61 $29K 133,269
2023-08-14 Litvack Frank Director Option exercise · Stock Option (Right to Buy) −20,748 0
2023-02-21 Litvack Frank Director Option exercise +14,027 $1.39 $19K 141,800
2023-02-21 Litvack Frank Director Shares withheld for taxes −4,524 $4.31 $19K 137,276
2023-02-21 Litvack Frank Director Option exercise · Stock Option (Right to Buy) −14,027 0
2023-01-03 Litvack Frank Director Grant or award · Stock Option (Right to Buy) +185,000 185,000
2022-01-03 Litvack Frank Director Option exercise +154,543 $1.39 $215K 174,934

Page 1 of 3 · 51 trades